Articles with "icosapent ethyl" as a keyword



Photo from wikipedia

Icosapent Ethyl Supplementation and Cardiovascular Prevention-Implications of Evolving Data.

Sign Up to like & get
recommendations!
Published in 2022 at "JAMA cardiology"

DOI: 10.1001/jamacardio.2022.3701

Abstract: This Viewpoint discusses the findings of the Reduction of Cardiovascular Events With Icosapent Ethyl Intervention Trial regarding the use of icosapent ethyl in moderate- to high-risk patients with fasting triglyceride levels greater than 135 mg/dL. read more here.

Keywords: icosapent ethyl; icosapent; cardiovascular prevention; ethyl supplementation ... See more keywords
Photo from wikipedia

Cost-effectiveness of Icosapent Ethyl for High-risk Patients With Hypertriglyceridemia Despite Statin Treatment

Sign Up to like & get
recommendations!
Published in 2022 at "JAMA Network Open"

DOI: 10.1001/jamanetworkopen.2021.48172

Abstract: Key Points Question What is the cost-effectiveness of icosapent ethyl from a US health care perspective for high-risk patients with hypertriglyceridemia despite statin treatment? Findings This economic evaluation including 8179 patients found that icosapent ethyl… read more here.

Keywords: risk patients; icosapent ethyl; cost; high risk ... See more keywords
Photo by sammiechaffin from unsplash

Rationale and design of the pragmatic randomized trial of icosapent ethyl for high cardiovascular risk adults (MITIGATE)

Sign Up to like & get
recommendations!
Published in 2021 at "American Heart Journal"

DOI: 10.1016/j.ahj.2021.01.018

Abstract: Objective: The MITIGATE study aims to evaluate the real-world clinical effectiveness of pre-treatment with icosapent ethyl (IPE), compared with usual care, on laboratory-confirmed viral upper respiratory infection (URI)-related morbidity and mortality in adults with established… read more here.

Keywords: risk; risk adults; cardiovascular risk; icosapent ethyl ... See more keywords
Photo from wikipedia

Hypertriglyceridaemia — REDUCE-IT with icosapent ethyl

Sign Up to like & get
recommendations!
Published in 2018 at "Nature Reviews Cardiology"

DOI: 10.1038/s41569-018-0129-2

Abstract: Nature reviews | C a r d i o l o g y Use of icosapent ethyl is associated with a reduction in triglyceride levels and ischaemic events, including cardiovascular death, according to the results… read more here.

Keywords: icosapent ethyl; triglyceride levels; ethyl; risk ... See more keywords
Photo from wikipedia

REDUCE-IT: outcomes by baseline statin type

Sign Up to like & get
recommendations!
Published in 2020 at "European Heart Journal"

DOI: 10.1093/ehjci/ehaa946.3341

Abstract: REDUCE-IT (Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial) randomized 8,179 statin-treated patients with elevated triglycerides and increased cardiovascular (CV) risk to either icosapent ethyl (IPE), a pure, stable prescription form of eicosapentaenoic acid, 4g/day… read more here.

Keywords: ldl changes; statin type; statin; icosapent ethyl ... See more keywords
Photo by javad_esmaeili from unsplash

Profound reductions in first and total cardiovascular events with icosapent ethyl in the REDUCE-IT trial: why these results usher in a new era in dyslipidaemia therapeutics

Sign Up to like & get
recommendations!
Published in 2019 at "European Heart Journal"

DOI: 10.1093/eurheartj/ehz778

Abstract: Abstract The aims of this clinical review are to: (i) highlight the importance of elevated baseline triglycerides (TG) in the setting of well-controlled low-density lipoprotein cholesterol (LDL-C) on statins as a major contributor to residual… read more here.

Keywords: trial; events icosapent; trial results; profound reductions ... See more keywords
Photo by sammiechaffin from unsplash

The role of icosapent ethyl in cardiovascular risk reduction

Sign Up to like & get
recommendations!
Published in 2021 at "Current Opinion in Cardiology"

DOI: 10.1097/hco.0000000000000873

Abstract: Purpose of review Elevated levels of triglycerides, independent of low-density lipoprotein cholesterol (LDL-C) levels and statin therapy, are associated with heightened cardiovascular risk. Recent findings Mixed omega-3 fatty acid formulations, which contain varying amounts of… read more here.

Keywords: risk reduction; icosapent ethyl; risk; cardiovascular risk ... See more keywords

Effect of icosapent ethyl on susceptibility to ventricular arrhythmias in postinfarcted rat hearts: Role of GPR120‐mediated connexin43 phosphorylation

Sign Up to like & get
recommendations!
Published in 2020 at "Journal of Cellular and Molecular Medicine"

DOI: 10.1111/jcmm.15575

Abstract: The ω‐3 fatty acids exert as an antioxidant via the G protein‐coupled receptor 120 (GPR120). Icosapent ethyl, a purified eicosapentaenoic acid, showed a marked reduction in sudden cardiac death. Connexin43 is sensitive to redox status.… read more here.

Keywords: icosapent ethyl; gpr120; connexin43; phosphorylation ... See more keywords
Photo from wikipedia

Icosapent ethyl: scientific and legal controversies

Sign Up to like & get
recommendations!
Published in 2021 at "Open Heart"

DOI: 10.1136/openhrt-2021-001616

Abstract: Icosapent ethyl (Vascepa) is a purified preparation of the omega-3 fatty acid eicosapentaenoic acid, which is marketed by Amarin Pharma based in Ireland. The product was initially approved by the US Food and Drug Administration… read more here.

Keywords: ethyl; ethyl scientific; icosapent ethyl; cardiovascular events ... See more keywords
Photo from wikipedia

Fish Oil Supplements May Increase the Risk for Atrial Fibrillation: What Does This Mean?

Sign Up to like & get
recommendations!
Published in 2021 at "Circulation"

DOI: 10.1161/circulationaha.121.057464

Abstract: For decades, there has been interest in the role of omega-3 fatty acids (O3FAs) for the prevention of cardiovascular disease (CVD). Associations between fatty fish or O3FA consumption and lower incidences of CVD and mortality… read more here.

Keywords: fish oil; oil supplements; risk; icosapent ethyl ... See more keywords
Photo by joelfilip from unsplash

Abstract 57: Reduction in Ischemic Stroke With Icosapent Ethyl - Insights From REDUCE-IT

Sign Up to like & get
recommendations!
Published in 2021 at "Stroke"

DOI: 10.1161/str.52.suppl_1.57

Abstract: Background: In patients at elevated cardiovascular risk, statins reduce the occurrence of ischemic stroke. However, residual stroke risk persists. Methods: REDUCE-IT, a multinational, double-blind ... read more here.

Keywords: ischemic stroke; abstract reduction; reduction ischemic; stroke ... See more keywords